Liver Cancer Trial, Recruiting NCT07392567 Sponsor: Tongji Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT07392567
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years, of any gender
  • People who have been diagnosed with primary colon or rectal cancer (a specific type called adenocarcinoma) at an early to intermediate stage (Stage I, II, or III), and who are planned to have surgery to remove the cancer with the aim of a cure
  • People who have had a detailed CT scan of the abdomen and pelvis (with contrast dye) within one month before surgery, with clear enough image quality to be usable
  • People whose cancer has not spread to other parts of the body, including the liver, based on pre-surgery tests
  • People with a good general level of physical functioning, meaning they are either fully active or able to carry out light activity (this is measured using a standard medical scale called the ECOG scale, scores 0 or 1)
  • People, or their legal representative, who agree to take part and sign a consent form

Who may not be able to join:

  • People whose post-surgery tissue analysis shows the cancer is not the specific type (adenocarcinoma) this trial is studying, or that the cancer had already spread
  • People where the surgery did not fully remove all visible cancer, or where only palliative (comfort-focused) surgery or a stoma procedure was performed
  • People who have had another type of cancer at any point in their life
  • People who have previously had liver surgery or a liver transplant
  • People who pass away within 30 days after surgery
  • People who decline follow-up appointments, withdraw their consent to participate, or cannot be contacted for follow-up

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13636076910

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tongji Hospital
Registry
ClinicalTrials.gov
Start date
30 January 2026
Est. completion
30 January 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Area Under the Receiver Operating Characteristic Curve (AUC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov